The primary markers for gliomas include isocitrate dehydrogenase (IDH), classified as IDH-mutant, 1p/19q-non-codeleted (IDHmut-Noncodel), and IDH wild-type (IDHwt). Here, IDH1 is linked to central nervous system cancer.